Literature DB >> 25809145

Penicillium marneffei infection in a lung transplant recipient.

A Stathakis1, K P Lim2, P Boan1, M Lavender2, J Wrobel2, M Musk2, C H Heath1,3.   

Abstract

Penicillium marneffei is a thermally dimorphic fungus that can cause severe opportunistic infections in endemic regions of Southeast Asia, particularly in individuals infected with human immunodeficiency virus-1, but has rarely been reported in solid organ transplant recipients. Herein, we report the first case, to our knowledge, of P. marneffei infection in a lung transplant recipient, occurring in a 41-year-old woman 28 months post lung transplantation, after recent travel to Vietnam. We have reviewed the literature to derive some management principles for this rare infection in this clinical context. The number of P. marneffei infections in transplant recipients may increase, as a result of increasing rates of transplantation and travel to endemic areas.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Penicillium marneffei; Talaromyces marneffei; itraconazole; liposomal amphotericin B; renal transplant; travel; voriconazole

Mesh:

Substances:

Year:  2015        PMID: 25809145     DOI: 10.1111/tid.12377

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  10 in total

Review 1.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

2.  Clinical Characteristics of Transplant Recipients Infected with Talaromyces Marneffei: 2 Case Reports and a Literature Review.

Authors:  Suke Xing; Hui Zhang; Ye Qiu; Mianluan Pan; Wen Zeng; Jianquan Zhang
Journal:  Infect Drug Resist       Date:  2022-06-03       Impact factor: 4.177

3.  Successful treatment of pulmonary invasive fungal infection by Penicillium non-marneffei in lymphoblastic lymphoma: case report and literature review.

Authors:  Isabel Ramírez; Alicia Hidrón; Ricardo Cardona
Journal:  Clin Case Rep       Date:  2018-05-02

4.  Talaromyces marneffei infection in a non-HIV non-endemic population.

Authors:  Miriams Teresita Castro-Lainez; Miguel Sierra-Hoffman; Juan LLompart-Zeno; Robin Adams; Alan Howell; Holly Hoffman-Roberts; Robert Fader; Alejandro C Arroliga; Chetan Jinadatha
Journal:  IDCases       Date:  2018-03-03

Review 5.  Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis.

Authors:  Carol A Kauffman
Journal:  J Fungi (Basel)       Date:  2019-07-18

6.  LncSSBP1 Functions as a Negative Regulator of IL-6 Through Interaction With hnRNPK in Bronchial Epithelial Cells Infected With Talaromyces marneffei.

Authors:  Yinghua Li; Huan Chen; Shuyi Li; Yu Li; Guangnan Liu; Jing Bai; Honglin Luo; Xiuwan Lan; Zhiyi He
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

Review 7.  Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms.

Authors:  Kritsada Pruksaphon; Joshua D Nosanchuk; Kavi Ratanabanangkoon; Sirida Youngchim
Journal:  J Fungi (Basel)       Date:  2022-02-19

8.  NLRP3 Inflammasome Contributes to Host Defense Against Talaromyces marneffei Infection.

Authors:  Haiyan Ma; Jasper F W Chan; Yen Pei Tan; Lin Kui; Chi-Ching Tsang; Steven L C Pei; Yu-Lung Lau; Patrick C Y Woo; Pamela P Lee
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

Review 9.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

10.  Proteomic analysis of serum proteins from HIV/AIDS patients with Talaromyces marneffei infection by TMT labeling-based quantitative proteomics.

Authors:  Yahong Chen; Aiqiong Huang; Wen Ao; Zhengwu Wang; Jinjin Yuan; Qing Song; Dahai Wei; Hanhui Ye
Journal:  Clin Proteomics       Date:  2018-12-21       Impact factor: 3.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.